BCHE and Alzheimer disease: Importantly, LR5 treatment effectively restored microbiota diversity, an effect that was not observed with treatment with donepezil, a commonly used cholinesterase inhibitor in patients with AD (Li Y. et al., 2023; Jo et al., 2022).